JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, R. R.
Right arrow Articles by Slavin, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, R. R.
Right arrow Articles by Slavin, J. L.
Journal of the American College of Nutrition, Vol. 20, No. 4, 279-285 (2001)
Published by the American College of Nutrition


Original Research

Effects of Dietary Arabinogalactan on Gastrointestinal and Blood Parameters in Healthy Human Subjects

Ramona R. Robinson, MS, RD, Joellen Feirtag, PhD and Joanne L. Slavin, PhD, RD

Department of Food Science and Nutrition, University of Minnesota, St. Paul, Minnesota

Address reprint requests to: Joanne Slavin, Ph.D., Department of Food Science and Nutrition, 1334 Eckles Avenue, St. Paul, MN 55108. E-mail: jslavin{at}umn.edu

Objectives: Arabinogalactan (AG) is a non-digestible soluble dietary fiber that resists hydrolytic enzyme action and enters the large bowel intact where it is fermented by resident microflora. To determine whether AG has similar physiological properties to other soluble dietary fibers, we examined the effect of 15 and 30 g per day of a commercially available AG from Western Larch on several gastrointestinal and blood parameters.

Methods: Gastrointestinal parameters included fecal microflora, fecal enzyme activity, fecal short-chain fatty acids, fecal pH, fecal weight, transit time and bowel frequency. Blood parameters included total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, Apo-A1, Apo-B, glucose and insulin. The study consisted of two three-week diet treatments with no washout period. Participants (n=20, 11 males, 9 females) consumed their usual diet in addition to 15 or 30 g AG in a beverage sweetened with aspartame as compared to their usual diet with the control beverage.

Results: Significant increases in total fecal anaerobes were observed with 15 g (p=0.01) and 30 g AG (p=0.001). A significant increase (p=0.02) in Lactobacillus spp. was observed when subjects consumed AG for a total of six weeks regardless of dose. There were no significant changes in other microflora, fecal enzyme activity, transit time, frequency, fecal weight, fecal pH and short-chain fatty acids. Fecal ammonia levels decreased with 15 g (p=0.001) and 30 g (p=0.002) AG. No significant changes in blood lipids or blood insulin were observed.

Conclusions: These data suggest that dietary AG is easily incorporated into the diet, well tolerated in subjects and has some positive effects on fecal chemistry.

Key words: arabinogalactan, microflora, ammonia, blood lipids, gastrointestinal transit time




This article has been cited by other articles:


Home page
GlycobiologyHome page
R. L Schnaar and H. H Freeze
A "Glyconutrient Sham"
Glycobiology, September 1, 2008; 18(9): 652 - 657.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Nutrition.